The Jewish Hospital - Mercy Health Hosts Local Update from the 59th Annual American Society of Hematology Meeting on Saturday, February 10

Mercy Health - Cincinnati, which provides advanced, quality, compassionate care in your neighborhood through its care network, announces that The Jewish Hospital - Mercy Health and the Mercy Health Foundation are presenting updates from the 59th Annual Meeting of the American Society of Hematology (ASH). The local update takes place on Saturday, February 10, at the Westin Hotel, located at 21 E. 5th St., Cincinnati, Ohio 45202.

 

The annual meeting of ASH is the preeminent medical forum for sharing information on the latest scientific advances in the diagnoses and treatment of blood cancer and disorders. The Jewish Hospital’s 2018 Tri-State ASH Update will bring national experts in hematology oncology research and clinical practice together with community-based practitioners. The setting will facilitate personal interaction for attendees to learn current best practice in blood cancer and disorders treatment in addition to advancements presented at the 59th ASH Annual Meeting and Exposition.

 

At the conclusion of this learning event, attendees will be familiar with:

  • the molecular pathogenesis of hematologic malignancies
  • new diagnostic and therapeutic approaches to common hematologic disorders
  • the results from the most recent disease-specific clinical trials and their translation into clinically and medically relevant contexts.

 

Keynote speakers include:

  • H. Joachim Deeg, MD, Member, Clinical Research Division, Fred Hutchinson Cancer Research Center; Professor, Division of Medical Oncology, University of Washington School of Medicine
  • Elihu Estey, MD, Professor, Division of Hematology, University of Washington School of Medicine; Member, Fred Hutchinson Cancer Research Center
  • Ching-Hon Pui, MD, Member, St. Jude Faculty; Chair, Oncology Department; Co-Leader, Hematological Malignancies Program; Medical Director, China Program, St. Jude Global; American Cancer Society Professor; Fahad Nassar Al-Rashid Chair of Leukemia Research
  • Stephen J. Schuster, MD, University of Pennsylvania School of Medicine; Director, Lymphoma Program & Lymphoma Translational Research; Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research
  • Paul Richardson, MD, Clinical Program Leader and Director of Clinical Research, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School

 

Guest speakers include:

  • Charles Schiffer, MD, Professor, Medicine and Oncology, Wayne State University; Joseph Dresner Chair for Hematologic Malignancies, Karmanos Cancer Institute; Director, Leukemia/Lymphoma Multidisciplinary Program
  • Karen Ballen, MD, Professor of Medicine, University of Virginia; Section Chief, Hematology, Hematological Malignancy and Stem Cell Transplant
  • Frederick B. Hagemeister, MD, Internist and Professor of Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center

 

Cost to attend is $50-$125 and the event is accredited for seven CMEs. For more information, agenda details and to register to attend, please visit https://foundation.mercy.com/hematology.

 

The event’s platinum sponsor is Johnson & Johnson. Exhibiting sponsors include Novartis, The Medicine CO, Incyte, Sanofi Genzyme, Pharmacyclics, Celgene, Amgen, Pfizer, Jazz Pharmaceuticals, Takeda, AbbVie, Seattle Genetics, Gilead, Astra Zeneca, BTG Pharmaceuticals.